|
시장보고서
상품코드
2084815
체외막산소공급장치(ECMO) 시장 : 방식별, 용도별, 연령층별, 지역별Extracorporeal Membrane Oxygenation System Market, By Modality, By Application, By Age Group, By Geography |
||||||
체외막산소공급장치(ECMO) 시장은 2026년에 3억 9,500만 달러 규모가 될 것으로 추정되며, 2033년까지 5억 7,100만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 5.4%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 3억 9,500만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 5.40% | 예측 금액(2033년) | 5억 7,100만 달러 |
체외막산소공급장치(ECMO)는 체외에서 심폐 기능을 보조하는 장치입니다. 체외막산소공급장치(ECMO)는 배액 및 재주입 위치에 따라 동맥-정맥형, 정맥-동맥형, 정맥-정맥형의 세 가지 유형으로 나뉩니다. 한편, 연령에 따라 ECMO 시스템은 신생아용, 소아용, 성인용으로 분류됩니다. 캐뉼라의 배액 포트와 재주입 포트의 위치에 따라 ECMO 시스템의 방식이 결정됩니다. 배액과 재주입이 모두 중심정맥을 통해 이루어지는 경우를 정맥-정맥형 ECMO라고 하며, 정맥에서 동맥으로 이루어지는 경우를 정맥-동맥형 ECMO라고 합니다. ECMO는 폐나 심장 질환으로 인해 위중한 상태에 있는 분, 또는 심장 이식을 대기 중이거나 회복 중인 분들에게 도움이 됩니다. 다른 생명 유지 조치가 효과를 보이지 않을 때 사용되기도 합니다. ECMO는 질환을 치료하거나 완치시키는 것은 아니지만, 신체가 조직에 충분한 산소를 공급하지 못할 때 일시적으로 신체를 보조할 수 있습니다.
선천성 심장 질환의 증가에 따라 ECMO에 대한 수요도 높아지고 있습니다. 예를 들어, 미국심장협회(American Heart Association)에 따르면, 미국에서는 매년 약 4만 명의 영아가 선천성 심장병을 앓고 태어나며, 약 200만에서 300만 명이 선천성 심장병을 앓으며 생활하고 있습니다.
시장 역학
ECMO 시장의 성장은 천식, 만성 폐쇄성 폐질환(COPD), 직업성 폐질환, 폐고혈압증 등 심혈관질환 및 만성 호흡기질환의 유병률 증가와 같은 요인에 기인합니다. 예를 들어, 세계보건기구(WHO)가 2022년 5월에 발표한 자료에 따르면, 만성 폐쇄성 폐질환(COPD)은 전 세계 사망 원인 중 3위를 차지하며, 2019년에는 323만 명이 이로 인해 사망했습니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 체외막산소공급장치(ECMO) 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 체외막산소공급장치(ECMO) 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 체외막산소공급장치(ECMO) 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 체외막산소공급장치(ECMO) 시장 : 방식별(2021-2033년)
제5장 세계의 체외막산소공급장치(ECMO) 시장 : 용도별(2021-2033년)
제6장 세계의 체외막산소공급장치(ECMO) 시장 : 연령층별(2021-2033년)
제7장 세계의 체외막산소공급장치(ECMO) 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KSM 26.07.20Extracorporeal Membrane Oxygenation System Market is estimated to be valued at USD 395 Mn in 2026 and is expected to reach USD 571 Mn by 2033, growing at a compound annual growth rate (CAGR) of 5.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 395 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.40% | 2033 Value Projection: | USD 571 Mn |
Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are three different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial, and venovenous. Whereas, on the bases of age, ECMO systems are classified into neonatal, pediatric and adult. . The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. ECMO is helpful for people who are very ill with conditions of the lungs and heart, or who are awaiting for or recovering from a heart transplant. It may be used when other life support measures do not work. ECMO does not treat or cure a disease, but can assist the body temporarily when it is not able to provide the tissues with enough oxygen.
Growing number of congenital heart defects, increase demand for ECMO. For instance, according to American Heart Association, approximately 40,000 infants are born with a congenital heart defect in U.S. each year and around 2 to 3 million individuals are living with a congenital heart defect.
Market Dynamics
Growth of ECMO market is due to factors such as increasing prevalence of cardiovascular and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, according to data published by the World Health Organization, in May 2022, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global extracorporeal membrane oxygenation system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global extracorporeal membrane oxygenation system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracorporeal membrane oxygenation system market
Market Segmentation
- By Modality Insights (Revenue, USD Mn, 2021 - 2033)
- Arteriovenous
- Venoarteial
- Venovenous
- By Application Insights (Revenue, USD Mn, 2021 - 2033)
- Extracorporeal cardiopulmonary resuscitation
- Cardiac
- Respiratory
- By Age Group Insights (Revenue, USD Mn, 2021 - 2033)
- Neonatal
- Pediatric
- Adults
- By Region Insights (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players
- Medtronic
- Getinge AB
- LivaNova PLC
- Terumo Corporation
- XENIOS AG
- OriGen Biomedical
- EUROSETS
- NIPRO
- MicroPort Scientific Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Modality
- Market Snapshot, By Application
- Market Snapshot, By Age Group
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Technological Advancements
- PEST Analysis
- PORTER'S Five Forces
4. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Arteriovenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Venoarteial
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Venovenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
5. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Extracorporeal cardiopulmonary resuscitation
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Cardiac
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Respiratory
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
6. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2021 - 2033, (USD Mn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Neonatal
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Pediatric
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
- Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Mn)
7. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2021 - 2033, (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022-2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- UK
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Modality, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033, (USD Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Mn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Terumo Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- XENIOS AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OriGen Biomedical
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- EUROSETS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- NIPRO
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- MicroPort Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
